Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Coluccio

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Gut|February 1, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Zonera Hassan, Christian Schneeweis, et al.
Nature Methods|June 16, 2022
Mass spectrometry-based draft of the mouse proteomePiero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Nature Cancer|February 5, 2022
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironmentChiara Falcomatà, Stefanie Bärthel, Sebastian A Widholz, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Gut|February 1, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Zonera Hassan, Christian Schneeweis, et al.
Nature Methods|June 16, 2022
Mass spectrometry-based draft of the mouse proteomePiero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Nature Cancer|February 5, 2022
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironmentChiara Falcomatà, Stefanie Bärthel, Sebastian A Widholz, et al.
Pageof 2